← Back to Search

Exercise Training for Long-Term COVID-19 Effects

N/A
Recruiting
Led By Bryan Taylor, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Deemed 'recovered' from SARS-CoV-2 infection
Aged 21 to 75 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

Study Summary

This trial is testing if exercise can help improve the long term effects of COVID-19, like lung and heart function.

Who is the study for?
This trial is for adults aged 21-75 who have recovered from COVID-19, confirmed by RT-PCR test. Participants should not be clinically obese or have conditions limiting exercise. They must be free of heart issues during rest and exertion and able to consent in writing.Check my eligibility
What is being tested?
The study aims to assess the long-term effects of COVID-19 on physical health and whether exercise training can improve lung and heart function, fitness levels, and reduce lingering symptoms in those recovering from the virus.See study design
What are the potential side effects?
While specific side effects are not listed for exercise training, typical risks may include muscle soreness, fatigue, shortness of breath during activity, or exacerbation of underlying conditions if present.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have been declared as fully recovered from a SARS-CoV-2 infection.
Select...
You are between 21 and 75 years old.
Select...
You are not severely overweight or have health conditions that make it hard for you to exercise.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Maximal oxygen update (VO2max) measured in mL/kg/min
Secondary outcome measures
Forced expiratory volume in 1 second (FEV1) measured in L
Forced vital capacity (FVC) measured in L
Left ventricular contractile function measured as % fractional area change (LV FAC)
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Interventional (exercise training) GroupExperimental Treatment1 Intervention
8 week home-based exercise training
Group II: Control GroupActive Control1 Intervention
Standard physician-guided medical care after COVID-19

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,191 Previous Clinical Trials
3,758,461 Total Patients Enrolled
Bryan Taylor, PhDPrincipal InvestigatorMayo Clinic
2 Previous Clinical Trials
80 Total Patients Enrolled

Media Library

Exercise Training Clinical Trial Eligibility Overview. Trial Name: NCT04913129 — N/A
Coronavirus Research Study Groups: Control Group, Interventional (exercise training) Group
Coronavirus Clinical Trial 2023: Exercise Training Highlights & Side Effects. Trial Name: NCT04913129 — N/A
Exercise Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT04913129 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to enroll in this clinical trial?

"Candidates aged 21-75 with a confirmed case of covid-19 will be considered for this trial. Approximately 50 participants are needed to participate in the study."

Answered by AI

What is the upper limit to patient enrollment in this research endeavor?

"Affirmative. The details available on clinicaltrials.gov demonstrate that recruitment for this medical experiment is taking place now, which was initially posted in November of 2021 and last amended in December of the same year. Specifically, 50 participants are being sought from a single location."

Answered by AI

Are participants actively being recruited for this study?

"As per information on clinicaltrials.gov, this medical trial commenced recruitment on November 4th 2021 and the details were recently revised on December 7th 2021 - thus, signifying that enrollment is still open to applicants."

Answered by AI

Are participants under 25 years old admissible to this medical study?

"This medical trial is recruiting patients aged between 21 and 75. There are 140 studies for younger people, and an additional 911 reviews available to those above the upper age limit."

Answered by AI
~15 spots leftby Mar 2025